Key Takeaways
- • Bain Capital has agreed to acquire Vitabiotics, the UK's leading vitamin, mineral, and supplement company, in a transaction valued at approximately $1.2 billion (£900 million), announced July 24, 2026.
- • The deal encompasses Vitabiotics' UK operations and the broader VB Group, including Meyer Organics in India and operations across Africa (including VB Egypt), positioning the company for accelerated international expansion across its 70+ country footprint.
- • Bain Capital's Asia Private Equity team will lead the investment with support from the firm's global platform, leveraging local market expertise in India and sector capabilities to drive growth in key markets including MENA and China.
- • The UK will remain central to Vitabiotics' brand, innovation, and category leadership, with no immediate operational changes; investment focus areas include digital capabilities, e-commerce, international distribution, supply chain resilience, and new product development.
- • The acquisition marks a significant consolidation milestone in the vitamins, minerals, and supplements (VMS) sector and signals Vitabiotics' next growth phase following its 55-year operating history.
Summary
Bain Capital, a leading global private investment firm, has agreed to acquire Vitabiotics Ltd., the UK's No. 1 vitamin company, in a transaction valued at approximately $1.2 billion (£900 million). The announcement, made on July 24, 2026, represents a major consolidation event in the vitamins, minerals, and supplements industry and marks a significant milestone in Vitabiotics' 55-year corporate history.
The transaction encompasses not only Vitabiotics' UK operations but also the broader VB Group infrastructure, including Meyer Organics in India and the company's African operations, notably VB Egypt. This comprehensive acquisition underscores Bain Capital's confidence in Vitabiotics' position as a globally recognized independent vitamins and supplements business with presence in over 70 countries. The deal structure reflects Bain's strategic intention to leverage the company's established international platform as a foundation for accelerated growth across multiple regions.
Bain Capital's Asia Private Equity team will lead the investment, supported by the firm's global capabilities and resources. The structure highlights Bain's commitment to deploying local market knowledge in India alongside sector-specific expertise to drive expansion. Management has identified key growth markets including the Middle East and North Africa (MENA) region and China as strategic priorities, where the combined entity will focus on scaling existing brands and strengthening distribution infrastructure.
Operationally, Vitabiotics will maintain business continuity with no immediate changes to day-to-day operations following close. The UK will remain central to the company's brand identity, innovation capacity, and category leadership. Investment priorities include enhancing digital capabilities, expanding e-commerce reach, strengthening international distribution networks, building supply chain resilience, and advancing new product development initiatives. This approach reflects Bain Capital's stated commitment to supporting long-term value creation while preserving the company's operational independence and strategic focus on consumer and partner delivery.
The transaction encompasses not only Vitabiotics' UK operations but also the broader VB Group infrastructure, including Meyer Organics in India and the company's African operations, notably VB Egypt. This comprehensive acquisition underscores Bain Capital's confidence in Vitabiotics' position as a globally recognized independent vitamins and supplements business with presence in over 70 countries. The deal structure reflects Bain's strategic intention to leverage the company's established international platform as a foundation for accelerated growth across multiple regions.
Bain Capital's Asia Private Equity team will lead the investment, supported by the firm's global capabilities and resources. The structure highlights Bain's commitment to deploying local market knowledge in India alongside sector-specific expertise to drive expansion. Management has identified key growth markets including the Middle East and North Africa (MENA) region and China as strategic priorities, where the combined entity will focus on scaling existing brands and strengthening distribution infrastructure.
Operationally, Vitabiotics will maintain business continuity with no immediate changes to day-to-day operations following close. The UK will remain central to the company's brand identity, innovation capacity, and category leadership. Investment priorities include enhancing digital capabilities, expanding e-commerce reach, strengthening international distribution networks, building supply chain resilience, and advancing new product development initiatives. This approach reflects Bain Capital's stated commitment to supporting long-term value creation while preserving the company's operational independence and strategic focus on consumer and partner delivery.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.